Page 179 - 20211214_OHKF_Health_Finance_Research_Report_E (1)
P. 179

Table 4.10
                                  Prevalence of Diabetes Mellitus and Prediabetes

                                  Parameters                                                  Value

                                  Prevalence of prediabetes (IFG)                             1.24%
                                  Prevalence of DM with prior diagnosis                       2.46%
                                  Prevalence of DM without history of diagnosis               4.86%


                             Using an average of the growth in prevalence of prediabetes in the data provided by Quan
                             and colleagues to substitute for the cumulative incidence proportion of prediabetes, we
                             calculated that the growth in incidence of prediabetes per year would be
                             0.99% (Quan et al., 2017).

                             To calculate the progression rate from prediabetes to DM, we used the resultant data from
                             Okada, Tsushita et al.’s 2017 Japan Ningen Dock study to explore the variation in impact of
                             prediabetes management and lifestyle modification on prediabetic patients (Okada et al.,
                             2017). Okada and colleagues’ study faced a four-year timeline and compared the cumulative
                             incidence of DM progression from prediabetes in two groups, the Ningen Dock study group
                             that received guidance on lifestyle modification, and a control group without comprehensive
                             guidance. The researchers found that the cumulative incidence of DM progression
                             in the study group was 11.2% (95% CI, 10.7–11.7%), compared to a cumulative
                             incidence in the control group of 14.9% (95% CI, 14.2–15.6%). We do not account
                             for the progression of prediabetes to DM in patients within the first year given that the
                             prevalence of different diagnostic states is already set in the 2014/15 PHS. After, our model
                             assumes that individuals will begin developing DM as early as the second year at an
                             incidence interval of 2.8% (per annum incidence derived from 11.2% cumulative incidence
                             every four years). Separately, we expect an annual cumulative incidence of DM progressing
                             from pre-diabetes as 3.73% for the Base Scenario (per annum incidence derived from 14.9%
                             cumulative incidence every four years).

                             The parameters used in the BIA are as follows (Table 4.11) (calculations can be found in
                             Appendix P):


                                Table 4.11

                                  Parameters list for model assumptions

                                  Parameters                                                   Value
                                  Starting points
                                  Prediabetes prevalence as at 2022                            1.24%
                                  Already have diagnosis before 2022                           2.46%
                                  Diabetic but without diagnosis before 2022                   4.86%
                                  Flow parameters
                                  Incidence of prediabetes from no diagnosis                   0.99%
                                  Base Case: Incidence of new DM cases from prediabetes cases  3.73%
                                  Scenario 1 & 2: Incidence of new DM cases from prediabetes cases  2.80%
                                  Regression rate from prediabetes to normoglycaemia           2.82%
                                  Scenario 1 & 2: Remission rate from DM to prediabetes        7.00%
                                  Assumed complication rate multiplier of 20+ years of DM history  150%




                                                                                                               177
   174   175   176   177   178   179   180   181   182   183   184